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Abstract
Mitogen Activated Protein Kinase (MAPK) pathways form the backbone of signal transduction 
within the mammalian cell. Here, we apply a systematic experimental and computational approach 
to map 2,269 interactions between human MAPK-related proteins and other cellular machinery 
and to assemble these data into functional modules. A core network of 641 interactions is 
supported by multiple lines of evidence including conservation with yeast. Using siRNA 
knockdowns, we reveal that a significant number of novel interactors can modulate MAPK 
mediated signaling. We uncover the Na-H exchanger NHE1 as a scaffold for a novel set of 
MAPKs, link HSP90 chaperones to MAPK pathways, and identify MUC12 as the human analogue 
to the yeast signaling mucin Msb2. This study makes available a large resource of MAPK 
interactions along with the accompanying clone libraries. It illustrates a methodology for probing 
signaling networks based on functional refinement of experimentally-derived protein interaction 
maps.
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The MAPK pathways are a collection of protein signaling cascades stimulated by a wide 
variety of extra-cellular signals, including growth factors, cytokines, and environmental 
stress1, 2. Upon activation, MAPK pathways regulate a large number of fundamental 
cellular functions, including differentiation, proliferation, and apoptosis, through the 
activation of specific transcription factors and other regulatory proteins3. Because of this 
central role in signal transduction, MAPK proteins have been repeatedly implicated in the 
pathogenesis of cancer and autoimmune diseases, leading to their selection as targets for 
drug development4. MAPK pathways are also well conserved over the eukaryotic kingdom 
from yeast to man, enabling study of their structure and kinetics through genetic analysis of 
model organisms2.
The canonical MAPK pathway consists of three sequentially-activated MAPK family 
members: a MAPK kinase kinase (MAP3K) which activates a MAPK kinase (MAP2K) 
which, in turn, activates a MAP kinase (MAPK). However, it is clear that this canonical 
pathway is embedded in a rich network of interactions with a wide variety of other 
components, including membrane receptors, transcription factors, kinase scaffolds, and 
extensive cross-talk with other activators and inhibitors of signaling5. It has been suggested 
that a systems-level approach will ultimately be necessary to map these additional 
components and to understand their MAPK-related functions3, 6.
Towards this goal, we pursued a combined experimental and computational approach to 
assemble a large resource of MAPK protein interactions and to illustrate methods to 
functionally explore this network. This work involved four steps: (1) A screen for physical 
interactions between MAPK proteins and the rest of the proteome, (2) An assessment of 
network quality and functional assessment of MAPK interactors through siRNA screening, 
(3) A specific analysis of the MAPK network to identify kinase scaffolds, illustrating how 
the network can be used as a resource to guide the discovery of novel protein functions, and 
(4) Identification of interaction modules and evolutionary conservation to aid in functional 
interpretation. Based on the MAPK network resource, we find evidence that the Na+/H+ 
exchanger NHE1 functions as a kinase scaffold, and we identify a conserved signaling 
cascade mediated by the signaling mucin MUC12.
RESULTS AND DISCUSSION
Characterization of a MAPK interactome
We assembled a human MAPK network comprised of protein interactions identified through 
a two-stage yeast two-hybrid (Y2H) screen. A primary Y2H screen was performed using 86 
MAPK-related bait proteins (Supplementary Fig. 1) selected by literature curation (see 
Methods). Included in these baits were 46 kinases (of which 27 were known MAP-family 
kinases), 14 transcription factors downstream of MAPK signals, and four proteins associated 
with membrane receptors (Fig. 1a). This effort yielded 1,496 protein-protein interactions 
among 1,096 proteins. As follow-up to this primary screen, we examined 2`1 secondary 
baits that had been detected as preys in the first stage (based on their availability as bait 
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cDNA clones). This round identified an additional 786 interactions for a total of 2,269 
unique interactions among 1,468 proteins (termed the MAPK Y2H network) 
(Supplementary Table 1). Bait and prey cDNA clones are available upon reqest.
Analysis of the MAPK Y2H network revealed 313 interactions involving MAP-family 
kinases and 422 involving other kinases. After removing the original baits, the MAPK Y2H 
network was found to be enriched for protein families known to be critical to MAPK 
signaling such as membrane proteins and transcription factors, suggesting numerous 
possible upstream and downstream components of MAPK cascades (Fig. 1a). The network 
was also highly enriched for proteins involved in cytoskeletal organization and RNA 
binding and processing. The significant number of cytoskeletal proteins identified in this 
study suggests the active regulation of microtubule dynamics by MAP kinases or the use of 
the cytoskeleton as an organizational scaffold in MAPK signaling; it has been postulated 
that up to one third of MAP-family kinases are associated with the microtubule 
cytoskeleton7.
Many members of the MAPK Y2H network had been implicated in previous screens for 
genes that function in MAPK signaling. We found that the network (with 86 original baits 
removed) was highly enriched for proteins that are phosphorylated in response to 
stimulation of HeLa cells with epidermal growth factor8 (EGF; 429 of 2,089 phosphorylated 
proteins; P < 10−170). We also found substantial overlap with a screen for kinase activation 
in fly: the MAPK Y2H network contained 734 genes with Drosophila homologs, 92 of 
which were shown to be required for the activation of extracellular signal-regulated kinases 
(ERK) by an unbiased RNAi screen9 (P < 10−13).
Assessment of MAPK network quality and function
To estimate the sensitivity of the interaction screen (the percentage of true interactions 
recovered), we assembled a Positive Reference Set (PRS) of interactions through curation of 
prior literature. This set contained 1,453 previously-reported interactions among proteins 
covered by the MAPK Y2H network (Methods). Of the interactions in the PRS, we found 
that 93 were recovered by the MAPK Y2H network, yielding a sensitivity of 6% (Fig. 1b). 
To assess the significance of this number, we next assembled a Random Reference Set 
(RRS) of interactions as in (10). The RRS was constructed by permutation of the PRS to 
form a non-overlapping set of random interactions, which approximates a set of non-
interacting protein pairs10. The MAPK Y2H network contained approximately 1% of these 
randomly-chosen interactions, indicating a ~6-fold enrichment for the PRS over random.
We found that sensitivity could be increased substantially based on two criteria: 1) 
Observation of an interaction multiple times during the Y2H screen, and 2) Whether the 
interaction was conserved with yeast. An interaction may be observed multiple times 
because, during Y2H screening, protein preys are pooled with a particular bait and 
successful bait-prey interactions are identified by individual colony selection and 
sequencing (Methods). A very large number of interactions in our study (551 interactions) 
were identified multiple times through multiple sequenced clones. Similarly, because 
MAPK pathways are well-conserved among eukaryotes2, evidence that orthologs of the bait 
and prey can interact in yeast increases the confidence in interaction. For interactions that 
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were multiply sampled or conserved, respectively, the sensitivity was 19% or 22%, 
representing a > 3-fold increase in comparison to the entire MAPK Y2H network (Fig. 1b). 
Based on these results, we combined the multiply-sampled interactions and conserved 
interactions to form a “Core MAPK Network” of 641 high-confidence interactions 
(including 47 interactions selected by both criteria) (Supplementary Table 2).
Evidence for physical interaction may or may not mean that interaction is functional. 
Although network function is difficult to assess systematically, classic studies of multiple 
MAPK pathways have shown that AP-1 or NFκB transcription factors are critical effectors 
of these pathways under appropriate stimulation11, 12. We therefore pursued a functional 
validation strategy based on guilt-by-association: given MAPK proteins that affect AP-1 or 
NFκB activation, siRNA knockdown of their functional interactors should also modulate 
these phenotypes. Using this strategy, we selected a panel of 14 MAPK interacting proteins 
from the MAPK Y2H Network and systematically knocked these down using four 
independent siRNAs per gene to mitigate possible off target effects. The response to each 
knockdown was assessed using AP-1 or NFκB transcriptional activation in response to 
phorbol-12-myristate-13-acetate (PMA) or tumor necrosis factor (TNF), respectively. We 
found that 36% of targeted genes had two or more independent siRNAs that were able to 
significantly reduce AP-1 levels (Fig. 1c, Supplementary Fig. 2). This rate was similarly 
high in the case of NFκB, with a rate of 29%. In contrast, siRNAs targeting of a set of 45 
random genes reduced NFκB levels for two of these (4%), roughly a tenth the rate of the 
tested MAPK interactors (Fig. 1c, Supplementary Fig. 2). This siRNA panel is not a true 
gold standard, such that failure to affect AP-1 or NFκB activity does not negate the 
corresponding protein-protein interaction, which might be involved in unrelated aspects of 
MAPK signaling. However, the analysis does show that the Core MAPK Network recovers 
approximately 20% of known interactions among these proteins and that approximately a 
third of interactions can be functionally validated using siRNA.
Kinase subnetworks identify NHE1 as a novel kinase scaffold
As an example of how the MAPK network can be used as a resource for identification of 
novel protein functions, we analyzed the network for evidence of MAPK scaffolds. MAPK 
scaffolds form a signaling apparatus through the simultaneous binding of kinases and their 
substrates13. To identify such scaffolds, we selected proteins that interact with multiple 
MAPK levels and have at least 40% of their interactions with kinases, yielding a total of 10 
candidate scaffolds (four of which are shown in Fig. 2a–d; Supplementary Table 3). As a 
positive control, this strategy detected a well-established human MAPK scaffold, the actin-
binding protein FLNA, which has been postulated to organize kinase signaling between the 
membrane and cytoskeleton and to regulate transcription factors such as AP-114. Of the 11 
interactions involving FLNA, seven are with kinases or transcription factors (Fig. 2a).
We found that the plasma membrane Na-H exchanger NHE1 interacted with a total of seven 
MAPK family proteins, spanning all four levels of the MAPK hierarchy including 
MAP4K4, two MAP3Ks (MAP3K7 and RAF1), MAP2K2, and three MAPKs (ERK1, 
ERK2, and JNK3) (Fig. 2b). NHE1 also interacted with the Rho GTPase Rac1, which can 
modulate NHE1 activity15. In addition to its known role in ion exchange, we postulated that 
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NHE1 may function as a plasma-membrane scaffold for the assembly of signaling 
complexes16. Using tagged NHE1, we confirmed the interaction between the C-terminal 
cytoplasmic domain of NHE1 and MAP3K7 (TAK1) in vitro (Fig. 2e). We also identified 
two independent siRNAs targeted to NHE1 that were able to significantly reduce 
phosphorylation levels of p38 in response to PMA, an established assay of MAPK pathway 
function (Fig. 2f). Thus, based on the new protein interactions and functional siRNA 
screening data, it is likely that the cytoplasmic tail of NHE1 promotes the assembly of a 
GTPase and MAP-family kinases into (possibly multiple) signaling complexes. As we 
previously showed that NHE1 binds to and is phosphorylated by MAP4K4 in response to 
external growth factors17, a similar mechanism might govern the activity of the other 
interactions identified here. Since MAP3K7 is activated by the transforming growth factor β 
(TGF-β) receptor18 and we have previously identified an NHE1-immune complex 
containing the type II TGF-β receptor, the new interaction data suggest that NHE1 can act as 
a regulatory molecule for processing various cell stimuli in union with the TGF-β receptor, 
MAP3K7 and other MAPKs19.
A number of novel interactions involving RANBP9 were also detected (Fig. 2c). Of 
particular interest is an interaction between RANBP9 and the RAPGEF2 guanine exchange 
factor, which is a member of the Ras subfamily of GTPases. RANBP9 was originally 
characterized as binding to the Ras GTPase-binding protein RAN and has been shown to 
activate the Ras signaling pathway20. Based on the Y2H evidence, we postulated that 
RANBP9 functions as a scaffold for RAPGEF2 and various MAPK kinases, including 
ERK3, and promotes activation of the transcription factors MAX, MEF2C, and JUN (a 
component of the AP-1 transcription factor). We found that siRNAs directed to RANBP9 
significantly reduced AP-1 transcription in response to PMA, in a manner similar to 
knockdown of the known scaffold FLNA (Fig. 2g). These experiments are consistent with a 
model whereby RANBP9 organizes MAPK signaling upstream of AP-1.
Network modules link MUC12 and HSP90 to MAPK proteins
To shed further light on the structure and function of the Core MAPK Network (Fig. 3a), we 
analyzed this network to extract conserved and/or species-specific modules (Methods). To 
form these modules, we first combined the Core MAPK Network with the Positive 
Reference Set to capture novel as well as literature-curated MAPK interactions. Network 
“modules” were identified as all complete interacting triplets of proteins (i.e., triangles) for 
which at least two interactions were from the Core MAPK Network. Triangles and other 
dense regions of interactions have been shown to be indicative of protein complexes, 
signaling pathways, and other functionally cohesive groups of proteins21. In total, 134 
triplets were found covering 195 core MAPK Y2H interactions (Supplementary Table 5). 
We next identified a subset of 19 “Conserved modules”, which were modules for which at 
least two of the interactions were conserved with yeast. We found that such modules fell 
into six connected components, highlighting potential conserved mechanisms of signaling 
and regulation (Fig. 3b–g).
One of these conserved modules included interactions of the MUC12 protein with p38 and 
Cdc42 (Fig. 3b), suggesting that MUC12 might function in a CDC42-responsive signaling 
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cascade. This hypothesis is supported through conservation with yeast, in which Cdc42 is 
found to interact with mucin family member Msb2 whose function in kinase signaling has 
already been established22. In support of a role for MUC12 in human MAPK signaling, we 
found that multiple distinct siRNA constructs against MUC12 could significantly 
knockdown both AP-1 activation (Fig. 3h) and p38 phosphorylation (Fig. 3i) in response to 
PMA. Together, the Y2H interaction and siRNA results suggest the existence of a novel 
human signaling mucin acting in an analogous fashion to the yeast mucin Msb2.
Another conserved module suggested a role for HSP90 members HSP90B1 and HSP90AB1 
in the function of MAPK6 (ERK3, Fig. 3c), perhaps to stabilize this protein in much the 
same way as HSP90B1 has been shown to stabilize ERBB223. These interactions are 
plausible since HSP90 proteins are known to associate with kinases that mediate multiple 
inputs24. To further investigate this hypothesis, we screened multiple siRNA constructs 
directed to HSP90AB1 and HSP90B1. We observed a reduction in levels of AP-1 
transcription (Fig. 3h) for HSP90AB1 and HSP90B1 as well as phosphorylated p38 (Fig. 3i) 
for HSP90AB1, suggesting a critical role for these HSP90 members in MAPK-mediated 
signaling.
We also identified three distinct network modules (Fig. 3j–l) which were not conserved with 
yeast. These modules either indicate interactions missing from the current yeast interactome 
map or machinery that may be present only in higher eukayotes. The modules highlight 
evidence for an interaction between RANBP2, the GTP-binding protein at the nuclear pore, 
and the APC tumor suppressor gene which is known to promote the association of the 
nuclear pore with microtubules25. Furthermore, these modules reveal a novel high-
confidence interaction between APC and the catenin CTNNA1 (Fig. 3j). Since interaction of 
APC with other β-catenin pathway members has been shown to be critical for WNT 
signaling, interactions of CTNNA1 with APC may play a role in this pathway as well. 
Because WNT signaling is conserved among metazoans but is not found in yeast, these 
examples illustrate the power of network mapping on a species-specific basis.
SUMMARY AND CONCLUSIONS
We have demonstrated a combined experimental and computational approach for the 
systematic expansion and refinement of protein networks based on high-throughput 
interaction mapping followed by functional validation and refinement. There have been a 
great many studies reported recently that start with a systematic siRNA screen and then 
interpret the top hits by projecting them onto a protein interaction network curated from 
literature26–28. Here, we reverse this workflow and start with a systematic interactome 
screen in preparation for targeted siRNA to interpret the high priority novel interactions. 
This methodology may be particularly useful for the study of cell functions that are not well 
covered by existing protein interaction maps published in prior literature. Moreover, such an 
approach adds functional value to basic interactome mapping efforts, a point which is 
particularly important given that only a very few previous protein interaction screens have 
addressed which interactions are functional29, 30.
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Beyond the methodological aspects, this work has led to the discovery of more than 2,000 
protein interactions related to MAPK proteins which, along with the associated cDNA clone 
libraries, constitute a significant resource for the research community. The quality of the 
network is comparable to previously-published Y2H datasets and can be substantially 
increased by techniques such as multiple sampling and cross species comparison. We have 
illustrated how this network can be analyzed to suggest novel kinase scaffolds, 
demonstrating that, in principle, numerous discoveries might be mined from these data. 
Other large-scale technologies such as gene expression profiling, co-affinity purification, 
and phospho-proteomics may add complementary facets of information, yielding a more 
complete understanding of MAPK signaling in humans and yeast.
MATERIALS AND METHODS
Y2H screening
Yeast strains and expression vectors for Y2H screening are as previously described33. 
Human protein baits were screened against preys derived from 22 different human cDNA 
libraries. The original 86 baits were selected based on BioCarta (http://www.biocarta.com/
pathfiles/m_p38mapkPathway.asp) as well as a review by Qi et al.34. Full experimental and 
computational details are provided in the Supplementary Methods. Interactions have been 
deposited into the BIOGRID database (www.thebiogrid.org). The yeast clones which harbor 
a specific bait-prey interaction pair are available upon request from the authors and can be 
used to confirm the bait ID, prey ID, amplify and clone bait or prey inserts, or verify an 
interaction by another method.
Literature-curated reference sets
To form the Positive Reference Set (PRS), a total of 23,978 literature-curated interactions 
were obtained from databases including BIND, HPRD and BioCarta (Supplementary Table 
4). To estimate sensitivity for each Y2H human protein interaction network the PRS was 
restricted to interactions involving proteins for which at least one interaction was observed 
in that network data set (Fig. 1b)10. To generate a Random Reference Set (RRS), the PRS 
was randomly permuted and any overlapping PRS interactions removed. One hundred such 
RRS datasets were generated and compared to each network dataset. For each Y2H network, 
the percent overlap with the RRS is summarized by its average and standard deviation of 
overlap.
Identification of conserved interactions
A yeast MAPK network was assembled from both literature-curated and experimental 
sources (for a listing see Supplementary Methods). A human protein interaction was 
considered “conserved” if both proteins had homologs that interacted in yeast. Human/yeast 
homologs were defined using a strict BLAST E-value < 10−10, and to avoid spurious 
matches due to large gene families we allowed no more than 10 yeast homologs for each 
human protein (10 best E-values). Of the 137 conserved interactions observed by this 
criteria, 21 (15%) were between sequence orthologs (Supplementary Table 2)35.
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AP-1 and NFκB luciferase siRNA assay
The HEK293 cell line stably expresses an AP-1 or NFκB responsive luciferase reporter as 
previously described32. An aliquot of 8×103 HEK293 cells was plated into 96-well tissue 
culture plates and each well transfected with 25 ng of indicated siRNA by using 
Lipofectamine2000 reagent (Invitrogen). After 72 h of transfection, cells were stimulated 
with 10ng/ml of PMA for 8 hours for the case of AP-1 or 10ng/ml of TNF for 8 hours in the 
case of NFκB. Luciferase activity was measured by using Bright Glow (Promega) according 
to the manufacturer instructions. Cell titer was measured by the CellTiter-Glo Luminescent 
Cell Viability Assay (Promega). Both cell titer and luciferase activity counts were 
normalized by the median of the scramble siRNAs36. All siRNA sequences are given 
(Supplementary Table 7).
Western blotting for phospho-p38 and in vitro binding assays
HeLa cells were transfected using RNAiMAX according to standard protocol (Invitrogen 
Life Technologies). After 72 h of transfection, cells were stimulated with 10ng/ml of PMA 
for 8 hours. Cells were lysed in buffer containing 25 mM Tris-HCl pH 7.6, 150 mM NaCl, 
1% NP-40, 1% Sodium deoxycholate, 0.1 % SDS, and phosphatase inhibitors (Sigma 
Aldrich). A 10 ng amount of cell lysate was resolved by SDS-PAGE, and blots were 
immunoblotted with the antibodies detecting the phosphorylated form of p38 (Promega). All 
blots were developed with HRP-conjugated secondary antibodies and ECL (Amersham 
Biosciences). In-vitro binding assays for N-terminal tagged NHE1 were performed as 
described previously31.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Functional properties of the MAPK network. (a) Breakdown of network proteins (columns 
1–3) and protein interactions (columns 4–10) by functional category. Enrichment p-value is 
based on the probability of identifying an equal or greater number of proteins in the same 
category at random assessed via the hypergeometric test with a background of 30,000 genes. 
(b) The percentage of Positive Reference Set or Negative Reference Set pairs overlapping 
with each network is shown. Error bars are s.e.m. (see Methods). (c) Percentage of MAPK 
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network genes which are able to knockdown AP-1 or NFκB activity. Random represents the 
percentage of forty-five randomly selected proteins which knockdown NFκB levels.
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Protein subnetworks reveal known and putative MAPK scaffolds. Network neighborhoods 
are shown for (a) Filamin protein FLNA, (b) the Na-H exchanger NHE1, (c) RAN binding 
protein RANBP9, and (d) the kinesin family member KIF26A. Newly-identified Y2H 
interactions (red) and interactions from literature are shown (blue). Proteins are colored 
based on their annotation as membrane (grey), MAPK (blue), transcription factor (red), or 
phosphorylated under EGF stimulation (yellow border)8. (e) Binding of in vitro-translated 
MAP3K7 (TAK1) to GST tagged C-terminus of NHE1 or GST alone. N-moesin, a known 
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NHE1 binding partner is used as a positive control31. Expressed input proteins used for in 
vitro binding assays are marked with asterisks. (f) Phosphorylated (pp38) and total levels of 
p38, assayed with and without PMA stimulation and two different siRNA knockdowns of 
NHE1. The bars quantify the pp38 / p38 ratio by image analysis of western blot. As a 
negative control, we observed nearly equal amounts of pp38 to p38 in the absence of PMA 
stimulation (−PMA). As a positive control, PMA stimulation with a scrambled siRNA 
induced p38 phosphorylation (Scramble, +PMA). (g) Using a luciferase reporter fused to the 
AP-1 gene, we tested the ability of various siRNAs to reduce AP-1 activation when 
stimulated with PMA32. As a negative control, scrambled siRNAs resulted in maximal 
AP-1 transcription (“Scramble”). As positive controls, siRNAs targeted to luciferase showed 
a large reduction of luminescence (“Luciferase”), and siRNAs directed directly to p38, 
upstream of AP-1, reduced signal intensity by 50%. Error bars represent s.e.m. with 6 
replicates.
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Functional modules in the core network. (a) Bird’s eye view of the core MAPK Y2H 
network. (b–g) High confidence conserved functional modules. Red edges correspond to 
core MAPK Y2H interactions which were conserved with yeast. Grey edges indicate core 
interactions not conserved with yeast. Thickness of the edge increases with the number of 
observations. (h) AP-1 luciferase activation assay for various siRNAs targeting members of 
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conserved modules. (i) p38 phosphorylation levels are decreased with siRNAs targeting 
members of conserved modules. (j–l) Novel modules not conserved with yeast.
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